Henry F. Hoff

6.5k citations

64 papers · 5.3k indexed · 2 hit papers · h-index 29

Immunology top 1%
Molecular Biology top 5%
Surgery top 2%
Biochemistry top 0.2%
Epidemiology top 5%

Co-authors: Eugene A. Podrez Stanley L. Hazen Roy L. Silverstein Maria Febbraio David P. Hajjar David Schmitt Robert G. Salomon June O’Neil
Topics: Atherosclerosis and Cardiovascular Diseases (25 papers)Antioxidant Activity and Oxidative Stress (22 papers)Cholesterol and Lipid Metabolism (15 papers)
Cited by: Biochemistry Immunology
Journals: Journal of Biological Chemistry Journal of Clinical Investigation Circulation Research
Partner nations: United States Austria India

In The Last Decade

Henry F. Hoff

64 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages

2002 818 citations Vidya Kunjathoor, Maria Febbraio et al. Journal of Biological Chemistry profile →
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

2000 816 citations Maria Febbraio, Eugene A. Podrez et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Henry F. Hoff

Since Specialization

Citations

This map shows the geographic impact of Henry F. Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry F. Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry F. Hoff more than expected).

Fields of papers citing papers by Henry F. Hoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry F. Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry F. Hoff. The network helps show where Henry F. Hoff may publish in the future.

Co-authorship network of co-authors of Henry F. Hoff

This figure shows the co-authorship network connecting the top 25 collaborators of Henry F. Hoff. A scholar is included among the top collaborators of Henry F. Hoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry F. Hoff. Henry F. Hoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium 2004 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·George Hoppe,June O’Neil,Henry F. Hoff,Jonathan E. Sears	33
2	Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor 2003 ·Free Radical Biology and Medicine ·Eugene A. Podrez,George Hoppe,June O’Neil,Henry F. Hoff	21
3	Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues 2002 ·Protein Science ·John W. Crabb,June O’Neil,Masaru Miyagi,Karen A. West,Henry F. Hoff	90
4	Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophagesbreakdown → 2002 ·Journal of Biological Chemistry ·Vidya Kunjathoor,Maria Febbraio,Eugene A. Podrez,Kathryn J. Moore,Lorna P. Andersson,(unknown),(unknown),Roy L. Silverstein,Henry F. Hoff,Mason W. Freeman	818
5	Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species 2000 ·Journal of Clinical Investigation ·Eugene A. Podrez,Maria Febbraio,Nader Sheibani,David Schmitt,Roy L. Silverstein,David P. Hajjar,Peter A. Cohen,William A. Frazier,Henry F. Hoff,Stanley L. Hazen	354
6	Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in micebreakdown → 2000 ·Journal of Clinical Investigation ·Maria Febbraio,Eugene A. Podrez,Jonathan D. Smith,David P. Hajjar,Stanley L. Hazen,Henry F. Hoff,Kavita Sharma,Roy L. Silverstein	816
7	Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro 1999 ·Journal of Clinical Investigation ·Eugene A. Podrez,David Schmitt,Henry F. Hoff,Stanley L. Hazen	412
8	Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein 1999 ·Journal of Biological Chemistry ·Robert G. Salomon,Wei Sha,Cynthia J. Brame,Kamaljit Kaur,Ganesamoorthy Subbanagounder,June O’Neil,Henry F. Hoff,L. Jackson Roberts	48
9	Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA 1998 ·Kidney International ·Eugene A. Podrez,(unknown),Robert G. Salomon,Martin J. Schreiber,Henry F. Hoff	12
10	Inactivation of Cathepsin B by Oxidized LDL Involves Complex Formation Induced by Binding of Putative Reactive Sites Exposed at Low pH to Thiols on the Enzyme 1997 ·Free Radical Biology and Medicine ·June O’Neil,George Hoppe,(unknown),Henry F. Hoff	38
11	Non-conventional modification of low density lipoproteins: chemical models for macrophage recognition of oxidized LDL 1997 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·George Hoppe,June O’Neil,Lawrence M. Sayre,Henry F. Hoff	10
12	Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid 1997 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·George Hoppe,Ganesamoorthy Subbanagounder,(unknown),Robert G. Salomon,Henry F. Hoff	34
13	Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation 1995 ·Current Opinion in Lipidology ·Henry F. Hoff,George Hoppe	19
14	Filipin staining of lipoproteins in polyacrylamide gels: Sensitivity and photobleaching of the fluorophore and its use in a double staining method 1994 ·Electrophoresis ·Gary B. Smejkal,Henry F. Hoff	5
15	Lp(a) and premature mortality during chronic hemodialysis treatment 1994 ·Chemistry and Physics of Lipids ·(unknown),(unknown),June O’Neil,Henry F. Hoff	14
16	Transverse pore gradient gel electrophoresis of lipoprotein [a] using methylenebisacrylamide gradients 1992 ·Electrophoresis ·Gary B. Smejkal,Henry F. Hoff	2
17	Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages 1988 ·Atherosclerosis ·Henry F. Hoff,June O’Neil	28
18	Localization of LDL in Arteries: Improvements in Immunofluorescence Procedures ^a 1983 ·Annals of the New York Academy of Sciences ·Henry F. Hoff,David L. Feldman,Ross G. Gerrity	4
19	Lipoproteins containing apolipoprotein A-I extracted from human aortas 1982 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Carol L. Heideman,Henry F. Hoff	23
20	Localization of Apo-Lipoproteins in Human Carotid Artery Plaques 1975 ·Stroke ·Henry F. Hoff,Carol L. Heideman,George P. Noon,John Stirling Meyer	8

About Henry F. Hoff

Henry F. Hoff is a scholar working on Biochemistry, Immunology and Surgery, having authored 64 papers that have together received 5.3k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (25 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Cholesterol and Lipid Metabolism (15 papers). The work is most often cited by research in Biochemistry (1.2k citations), Immunology (2.2k citations) and Biochemistry (332 citations). Henry F. Hoff has collaborated with scholars based in United States, Austria and India. Frequent co-authors include Eugene A. Podrez, Stanley L. Hazen, Roy L. Silverstein, Maria Febbraio, David P. Hajjar, David Schmitt, Robert G. Salomon, June O’Neil, John W. Gaubatz and Jonathan D. Smith. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact